Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma

British Journal of Cancer

Volumn 91, Issue 2, 2004, Pages 297-304

  Senff Ribeiro, A ^a   Echevarria, A ^b   Silva, E F ^b   Franco, C R C ^a   Veiga, S S ^a   Oliveira, M B M ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antimelanoma activity; Human melanoma cell lines; Mesoionic compounds; MI D

Indexed keywords

4 PHENYL 5 (4 NITROCINNAMOYL) 1,3,4 THIADIAZOLIUM 2 PHENYLAMINE CHLORIDE; AMPHOLYTE; DACARBAZINE; FIBRONECTIN; FOTEMUSTINE; LAMININ; MATRIGEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 3843133058     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601946     Document Type: Article

References (37)

1. Badachikar SV, Tikare RK, Puranik GS (1986) Synthesis, reactions and biological activity of 3-[p-(N-methyl/ethyl-N-phenylcarbamoyl)] phenylsydnones. Indian J Chem 25B: 1079-1080
2. Cadena SMSC, Carnieri EGS, Echevarria A, Oliveira MBM (1998) Effect of MI-D, a new mesoionic compound, on energy-linked functions of rat liver mitochondria. FEBS Lett 440: 46-50
3. Cadena SMSC, Carnieri EGS, Echevarria A, Oliveira MBM (2002) Interference of MI-D, a new mesoionic compound, on artificial and native membranes. Cell Biochem Funct 20: 31-37
4. Cheung KK, Echevarria A, Galembeck S, Maciel MAM, Miller J, Rumjanek VM, Simas AM (1992) Mesoionic compounds 3. Structure of the hydrochloride of 5-(4-methoxyphenyl)-1,3,4-thiadiazolium-2-phenylamine. Acta Crystallogr 48: 1471-1474
5. Colombo P, Gunnarsson K, Iatroupoulos M, Brughera M (2001) Toxicological testing of cytotoxic drugs (Review). Int J Oncol 19: 1021-1028
6. Corell T, Pedersen SB, Lissau B, Moilanen E, Mëtsa-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R, Marcinkiewicz E, Korbut R, Gryglewski RJ (1994) Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharmacol 46: 553-566
7. Engvall E, Ruoslahti E (1977) Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20: 1-5
8. Grynberg N, Gomes R, Shinzato T, Echevarria A, Miller J (1992) Some new aryl sydnones: effects on murine tumors. Anticancer Res 12: 1025-1028
9. Grynberg N, Santos AC, Echevarria A (1997) Synthesis and in vivo antitumor activity of new heterocycles derivatives of 1,3,4-thiadiazolium-2- aminide class. Anti-Cancer Drugs 8: 88-91
10. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776
11. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S (1992) Production of hydroxyl radicals from simultaneous generation of superoxide and nitric oxide. Biochem J 281: 419-424
12. Kankaanranta H, Rydell E, Peterson AS, Hohn P, Moilanen E, Corell T, Karup G, Vuorinen P, Pedersen SB, Wennmalm A, MetsaKeleta T (1996) Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol 117: 401-406
13. Keller BJ, Marsman DS, Popp JA, Thurman RG (1992) Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim Biophys Acta 1102: 237-244
14. Kier LB, Roche EB (1967) Medicinal chemistry of the mesoionic compounds. J Pharm Sci 56: 148-169
15. Kleinman HK, McGarvey ML, Kassel JR, Star VL, Cannon FB, Laurie GW, Martin GR (1986) Basement membrane complexes with biological activity. Biochemistry 25(2): 312-318
16. Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M (2000) Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin α5β1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res 256:434-444
17. Lopez MM, Kosk-Kosika P (1997) Entropy-driven interactions of anesthetics with membrane proteins. Biochemistry 36: 8864-8872
18. Majid PA, DeFeyter PJF, Van der Wall EE, Wardeh R, Ross JP (1980) Molsidomine in the treatment of patients with angina pectoris. N Engl J Med 302: 1-6
19. Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M, Hayashi T, Kato T, Saiki I (1998) Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from blue-green alga, Spirulina platensis. Clin Exp Metast 16: 541-550
20. Montanari CA, Beezer AE, Sandall JPB, Montanari MLC, Miller J, Giesbrecht AM (1992) On the interaction of some mesoionic compounds with Saccharomyces cerevisiae by biological microcalorimetry. Rev Microbiol 23: 274-278
21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63
22. Moustafa MAA, Eisa HM (1991) Synthesis and antimicrobial activity of 3-(substituted-phenyl)-sydnones. Arch Pharmacol 325: 397-401
23. Newell KJ, Tannock IF (1989) Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. Cancer Res 49: 4477-4482
24. Newton CG, Ramsden CA (1982) Meso-ionic heterocycles. Tetrahedron 38: 2965-3011
25. Ollis WD, Ramsden CA (1976) Meso-ionic compounds. Adv Heterocycl Chem 19: 1-121
26. Paulsson M, Aumailley M, Deutzmann R, Timpl R, Beck R (1987) Laminin - nidogen complex: extraction with chelating agents and structural characterization. Eur J Biochem 166: 11-19
27. Phillips HJ (1973) Dye exclusions tests for cell viability. In Tissue Culture, Methods and Applications, Kruse JR, Patterson JRMK (eds) pp 406-408, New York: Academic Press
28. Rehse K, Ciborski T, Müller B (1995) Platelet aggregation inhibiting and anticoagulant effects of oligoamines. XXVII: inhibition of leucocyte adherence to endothelium by oligoamine RE 1492C and the NO-donor RE 2047. Arch Pharm (Weinheim) 328: 125-126
29. Rehse K, Konig P (1995) New NO-donors with antithrombotic and vasodilating activities. XII. Mesoionic oxatriazoles and related monocyclic nitrosohydrazine derivatives. Arch Pharmacol 328: 137-142
30. Rudolph W, Derschinger J (1991) Clinical comparison of nitrates and sydnonimines. Eur Heart J 12: 33-41
31. Saiki I, Iida J, Murata J, Ogawa R, Nishi N, Sugimura K, Tokura S, Azuma I (1989) Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Cancer Res 49: 3815-3822
32. Satyanarayana K, Rao MNA (1995) Synthesis and anti-inflammatory, analgesics and antipyretic testing of 4-[1-oxo-(3-substituted aryl)-2-propenyl]-3-phenylsydnones and of 3-[4-[3-(substituted aryl)-1-oxo-2-propenyl] phenyl] sydnones. J Pharmacol Sci 84: 263-266
33. Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM (2003) Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res 13(5): 465-472
34. Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM (2004) Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anti-Cancer Drugs 15(3): 269-275
35. Shinzato TO, Grynberg N, Gomes RM, Echevarria A, Miller J (1989) Antitumor activity of new mesoionic compounds against three murine tumors. Med Sci Res 17: 865-866
36. Skulachev VP (1998) Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1363: 100-124
37. Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366: 151-165